In the complex world of pharmaceutical manufacturing, the quality and consistency of intermediates are paramount. One such crucial compound is N-Benzyl-6-(4-phenylbutoxy)hexan-1-amine, identified by CAS number 97664-55-6. This molecule serves as a vital building block in the synthesis of Salmeterol, a widely used long-acting beta-agonist for treating respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).

The synthesis of active pharmaceutical ingredients (APIs) is a multi-step process, and the efficiency and purity of each step directly impact the final product. N-Benzyl-6-(4-phenylbutoxy)hexan-1-amine, with its specific chemical structure, plays a critical role in forming the core framework of Salmeterol. Its purity, typically specified at ≥98.0%, is essential to avoid unwanted side reactions and impurities in the final drug substance. Manufacturers specializing in pharmaceutical intermediates understand the critical nature of these materials and adhere to strict quality control measures.

For procurement managers and R&D scientists seeking to buy this indispensable intermediate, partnering with a reliable manufacturer and supplier is key. A reputable supplier ensures not only the consistent quality of N-Benzyl-6-(4-phenylbutoxy)hexan-1-amine but also provides the necessary documentation and regulatory support that is often required in the pharmaceutical industry. The ability to secure a stable supply at a competitive price, especially when sourcing from China, can significantly impact production costs and timelines.

When considering a purchase, it’s important to look for suppliers who can offer comprehensive product details, including physical properties such as its off-white powder appearance, and chemical information like its molecular formula (C23H33NO) and molecular weight (339.51400). These details are crucial for process chemists and formulators to integrate the intermediate smoothly into their synthesis pathways.

Ultimately, the successful and cost-effective production of Salmeterol relies heavily on the quality of its precursors. By selecting a dependable manufacturer for N-Benzyl-6-(4-phenylbutoxy)hexan-1-amine, pharmaceutical companies can ensure the integrity of their API manufacturing process, leading to safer and more effective treatments for patients. For those looking to purchase or obtain a quote for this essential pharmaceutical intermediate, engaging with experienced suppliers is the most strategic approach.